Dietary Recommendations for Ethiopians on the Basis of Priority Diet-Related Diseases and Causes of Death in Ethiopia: An Umbrella Review.

Publication Year: 2023

DOI:
10.1016/j.advnut.2023.05.005

PMCID:
PMC10334157

PMID:
37182739

Journal Information

Full Title: Adv Nutr

Abbreviation: Adv Nutr

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nutritional Sciences

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Author disclosuresTHB, LT, IDB, JHMdV, NC, GK, DA, and EJMF, no conflicts of interest. Author disclosures THB, LT, IDB, JHMdV, NC, GK, DA, and EJMF, no conflicts of interest."

Evidence found in paper:

"Funding This research was funded by Agriculture for Nutrition and Health, FAO, Wageningen University and Research, and Ethiopian Public Health Institute as part of the Ethiopian Food-Based Dietary Guidelines Development project."

Evidence found in paper:

"The current review was registered on the PROSPERO international prospective register of systematic reviews in 2019, available at: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42019125490. Systematic reviews, meta-analyses, and narrative reviews published in English from 1 January, 2014 to 31 December, 2021, were identified in the following databases: 1) PubMed, 2) Scopus, and 3) Google and Google Scholar. Initially, 1513 articles were identified from a search strategy in PubMed and Scopus databases, including additional articles from Google Scholar. For title and abstract searching, we used the keywords of the selected priority diseases and causes of death in Ethiopia: CVD, T2DM, PEM, and micronutrients (vitamin A, zinc, calcium, and folate; see ). Each alternative keyword term was combined using “OR,” and all the different strings of keywords were connected using the “AND” operator. We included findings on overweight and obesity if they were reported as intermediate outcomes of CVD or T2DM. Food-based dietary guidelines (FBDG) need to be evidence-based. As part of the development of Ethiopian FBDG, we conducted an umbrella review to develop dietary recommendations. Protein-energy malnutrition (PEM), deficiencies of vitamin A, zinc, calcium, or folate, cardiovascular diseases (CVD), and type 2 diabetes mellitus (T2DM) were selected as a priority. Systematic reviews were eligible if they investigated the impact of foods, food groups, diet, or dietary patterns on priority diseases. After a search, 1513 articles were identified in PubMed, Scopus, and Google Scholar published from January 2014 to December 2021. The results showed that 19 out of 164 systematic reviews reported the impact of diet on PEM or micronutrient deficiencies. Daily 30–90 g whole-grain consumption reduces risk of CVD and T2DM. Pulses improve protein status, and consuming 50–150 g/d is associated with a reduced incidence of CVD and T2DM. Nuts are a good source of minerals, and consuming 15–35 g/d improves antioxidant status and is inversely associated with CVD risk. A daily intake of 200–300 mL of milk and dairy foods is a good source of calcium and contributes to bone mineral density. Limiting processed meat intake to <50 g/d reduces CVD risk. Fruits and vegetables are good sources of vitamins A and C. CVD and T2DM risks are reduced by consuming 200–300 g of vegetables plus fruits daily. Daily sugar consumption should be below 10% of total energy to lower risk of obesity, CVD, and T2DM. Plant-based fat has favorable nutrient profiles and modest saturated fat content. The association of saturated fatty acids with CVD and T2DM is inconclusive, but intake should be limited because of the low-density lipoprotein cholesterol-raising effect. Plant-based diets lower risk of CVD and T2DM but reduce micronutrient bioavailability. The review concludes with 9 key dietary recommendations proposed to be implemented in the Ethiopian FBDG. This review was registered at PROSPERO (CRD42019125490)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025